Does IRBESARTAN Cause Hyperkalaemia? 454 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 454 reports of Hyperkalaemia have been filed in association with IRBESARTAN (Irbesartan). This represents 4.5% of all adverse event reports for IRBESARTAN.
454
Reports of Hyperkalaemia with IRBESARTAN
4.5%
of all IRBESARTAN reports
24
Deaths
295
Hospitalizations
How Dangerous Is Hyperkalaemia From IRBESARTAN?
Of the 454 reports, 24 (5.3%) resulted in death, 295 (65.0%) required hospitalization, and 106 (23.3%) were considered life-threatening.
Is Hyperkalaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for IRBESARTAN. However, 454 reports have been filed with the FAERS database.
What Other Side Effects Does IRBESARTAN Cause?
Acute kidney injury (1,361)
Fall (795)
Hypotension (686)
Nausea (533)
Drug ineffective (532)
Malaise (488)
Hyponatraemia (485)
Fatigue (483)
Blood pressure increased (477)
Cough (438)
What Other Drugs Cause Hyperkalaemia?
METFORMIN (2,565)
SPIRONOLACTONE (2,518)
FUROSEMIDE (2,035)
RAMIPRIL (1,383)
SACUBITRIL\VALSARTAN (1,192)
SULFAMETHOXAZOLE\TRIMETHOPRIM (1,036)
LISINOPRIL (948)
POTASSIUM (944)
BISOPROLOL (850)
TACROLIMUS (713)
Which IRBESARTAN Alternatives Have Lower Hyperkalaemia Risk?
IRBESARTAN vs IRINOTECAN
IRBESARTAN vs IRON
IRBESARTAN vs IRON DEXTRAN
IRBESARTAN vs IRON ISOMALTOSIDE 1000
IRBESARTAN vs IRON POLYMALTOSE